Concepedia

Thomas Leiser

TL

Statistics

Publications

4

Citations

176

H-Index

4

Active since

2010

Affiliations

Imperial College London(Current)

Cancer Research UK

Thomas Leiser is an author at Imperial College London specializing in enzyme inhibition, drug discovery, and medicinal chemistry.

Publications per year

2010–2013

4

Publications

4

Defining the Mechanism of Action and Enzymatic Selectivity of Psammaplin A against Its Epigenetic Targets

Matthias G. J. Baud, Thomas Leiser, Patricia Haus et al. · Journal of Medicinal Chemistry · 2012 · 97 citations · Full text

, , +13

Thioester derivatives of the natural product psammaplin A as potent histone deacetylase inhibitors

Matthias G. J. Baud, Thomas Leiser, Vanessa Petrucci et al. · Beilstein Journal of Organic Chemistry · 2013 · 31 citations · Full text

, , +12

New synthetic strategies towards psammaplin A, access to natural product analogues for biological evaluation

Matthias G. J. Baud, Thomas Leiser, Franz‐Josef Meyer‐Almes et al. · Organic & Biomolecular Chemistry · 2010 · 29 citations

, , +16

Highly Ligand Efficient and Selective <i>N</i>‐2‐(Thioethyl)picolinamide Histone Deacetylase Inhibitors Inspired by the Natural Product Psammaplin A

Matthias G. J. Baud, Patricia Haus, Thomas Leiser et al. · ChemMedChem · 2012 · 19 citations

, , +17

1–4 of 4